About Careers MedBlog Contact us

Rule Out Heart Attacks Instantly With the New Portable Device

by Rishika Gupta on June 5, 2018 at 12:18 PM
Font : A-A+

 Rule Out Heart Attacks Instantly With the New Portable Device

Heart attacks can be diagnosed instantly with the help of a new cardiac myosin-binding protein C (cMyC) portable blood test device. Levels of cMyC have been found to rise after a heart attack, even to a greater extent than troponin. This principle in itself can rule out heart attacks instantly in a lot of people.

A new blood test being developed to diagnose heart attacks could one day be carried out on a simple handheld device, giving a rapid diagnosis in A&E departments without the need for samples to be sent to a lab, according to new research presented today at the British Cardiovascular Society Conference in Manchester.


The new test uses similar technology to the troponin test but analyses the level of a protein called cardiac myosin-binding protein C (cMyC). Levels of cMyC in the blood increase more rapidly after a heart attack, and to a greater extent than troponin, meaning that the test can rule out a heart attack in a higher proportion of patients straight away.

The international team, part-funded by the British Heart Foundation, took blood from 776 patients traveling to the hospital by ambulance in Denmark. Researchers based at King's College London then tested these samples for cMyC protein.

In patients who did suffer heart attacks, the protein was present in high enough concentrations 95 percent of the time for an on-the-spot diagnosis. Importantly, the cMyC test outperformed the existing troponin test, which was only capable of diagnosing around 40 percent of patients in this way. This is mainly because troponin takes longer to reach detectable levels in the blood after you suffer a heart attack.

The researchers now hope to work with industry to create a portable testing device to be used in UK A&E departments, and in ambulances in countries where these have to drive considerable distances to get patients to their nearest hospital. A simple handheld device could replace the time-consuming processes involved in sending samples to the hospital labs for analysis.

It is estimated that over two-thirds of people who attend A&E complaining of chest pain have not had a heart attack. But all will receive two tests: a heart test called an ECG and a blood test to measure the levels of a protein called troponin.

Under current guidelines, people suspected of having a heart attack are tested for high blood troponin levels as soon as they arrive in an A&E, and again after three hours. Depending on the type of troponin test used, up to 85 percent of people will need to remain in the hospital for further tests in order to rule out a heart attack.

The cMyC blood test, developed by a team from King's College London and tested across Europe, has already been shown to rapidly rule out a heart attack in more people than the standard troponin test. This could reassure worried patients in A&E departments, free up bed space and save hundreds of thousands of pounds per UK hospital every year.

Dr. Tom Kaier, one of the lead researchers, funded by the British Heart Foundation at St Thomas' Hospital, London said: "It is important for both patients and doctors to work out early who has had a heart attack and who hasn't."

"Now that we know that this test is sensitive enough to give an almost immediate heart attack diagnosis, we need to work on developing a testing device. We'd love to see this used in A&E departments within the next five years," said Dr. Kaiser.

Professor Jeremy Pearson, Associate Medical Director at the British Heart Foundation, said:

"Big heart attacks are often easy to diagnose with an ECG but smaller heart attacks, which are more common and also life-threatening, are more challenging. The troponin test has been used for around 20 years and is currently the most powerful tool we have for diagnosing such heart attacks, but there is always room for improvement.

"These initial results with the cMyC test look very promising for patients, who could be more quickly diagnosed and treated or reassured and sent home. However, further research is necessary before it can be recommended as a replacement for the troponin test."

Source: Eurekalert


Recommended Reading

Latest Heart Disease News

The Surprising Impact of Quit Smoking: 36% Lower Cardiovascular Risk
The study emphasizes the existing proof on the heart disease risks of tobacco smoking and the urgent need to stop smoking among cancer survivors.
 Discovering Genetic Risks for Type of Heart Attack Largely Affecting Younger Women
New study findings provide novel pathophysiological insights involving blood vessel integrity and tissue-mediated coagulation in a type of heart attack in young women.
Unlocking the Crystal Ball: Heart Failure Subtypes Helps Forecast Future Risks!
Recent study identifies five heart failure subtypes with the potential for individual patient risk prediction.
Is CT Scan the Best Way to Predict Heart Disease Risk?
In middle-age patients, CT scan identifies people who may benefit from drugs to decrease heart disease risk, stated study.
 People Having Strong Legs Are More Likely to Survive a Heart Attack
Researchers analyzed the link between muscle strength and the risk of developing heart failure in patients who had a heart attack without prior history of complications.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Rule Out Heart Attacks Instantly With the New Portable Device Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests